OTC, Supplement Industry Groups Target Returning Consumer Choice In Health Savings Accounts
This article was originally published in The Tan Sheet
Executive Summary
A federal agency's decision against extending a delay on requiring prescriptions for OTC drugs bought with pre-tax medical expense accounts galvanizes the consumer health care product industry's resolve to repeal the change.